James Hocker to Aged
This is a "connection" page, showing publications James Hocker has written about Aged.
Connection Strength
0.502
-
Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery. PLoS One. 2020; 15(8):e0234539.
Score: 0.090
-
Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients. Cancer Invest. 2017 Oct 21; 35(9):573-585.
Score: 0.074
-
Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling. Cancer Lett. 2015 Apr 10; 359(2):314-24.
Score: 0.062
-
Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling. Cancer Invest. 2014 May; 32(4):136-43.
Score: 0.058
-
Serum profiling to distinguish early- and late-stage ovarian cancer patients from disease-free individuals. Cancer Invest. 2012 Feb; 30(2):189-97.
Score: 0.050
-
Distinguishing non-small cell lung adenocarcinoma patients from squamous cell carcinoma patients and control individuals using serum profiling. Cancer Invest. 2012 Feb; 30(2):180-8.
Score: 0.050
-
Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry. Lung Cancer. 2011 Nov; 74(2):206-11.
Score: 0.048
-
Distinguishing early-stage pancreatic cancer patients from disease-free individuals using serum profiling. Cancer Invest. 2011 Feb; 29(2):173-9.
Score: 0.047
-
Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. PLoS One. 2015; 10(2):e0118933.
Score: 0.015
-
Biomarker identification in human pancreatic cancer sera. Pancreas. 2008 Jan; 36(1):61-9.
Score: 0.009